The extracellular release of HMGB1 is induced when cells are stimulated, and HMGB1 is considered an important new target for treating various inflammatory diseases, including brain injury and cancer (Sun and Chao, 2005; Das et al., 2021). This evidence concerns the gene HMGB1 and brain injury.